Zimmer Biomet Stock Price, News & Analysis (NYSE:ZBH)

$118.85 +1.27 (+1.08 %)
(As of 02/23/2018 04:00 PM ET)
Previous Close$117.58
Today's Range$117.62 - $118.94
52-Week Range$108.03 - $133.49
Volume626,474 shs
Average Volume1.42 million shs
Market Capitalization$24.03 billion
P/E Ratio13.12
Dividend Yield0.81%
Beta1.08

About Zimmer Biomet (NYSE:ZBH)

Zimmer Biomet logoZimmer Biomet Holdings, Inc. is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products. The Company's products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. The Company manages its operations through three geographic operating segments: the Americas, consisting principally of the United States and other North, Central and South American markets; EMEA, consisting principally of Europe and the Middle East and African markets, and Asia Pacific, consisting primarily of Japan and other Asian and Pacific markets. The Company's product category segments include Americas Spine, Office Based Technologies, Craniomaxillofacial and Thoracic (CMF), and Dental.

Receive ZBH News and Ratings via Email

Sign-up to receive the latest news and ratings for ZBH and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Equipment, Supplies & Distribution
Sub-IndustryN/A
SectorMedical
SymbolNYSE:ZBH
CUSIPN/A
Phone574-267-6131

Debt

Debt-to-Equity Ratio0.76%
Current Ratio1.52%
Quick Ratio0.83%

Price-To-Earnings

Trailing P/E Ratio13.1231964483907
Forward P/E Ratio15.20
P/E Growth2.08

Sales & Book Value

Annual Sales$7.82 billion
Price / Sales3.08
Cash Flow$14.99 per share
Price / Cash7.93
Book Value$58.07 per share
Price / Book2.05

Profitability

Trailing EPS$9.01
Net Income$1.84 billion
Net Margins23.51%
Return on Equity15.45%
Return on Assets6.17%

Miscellaneous

Employees18,500
Outstanding Shares202,470,000

Zimmer Biomet (NYSE:ZBH) Frequently Asked Questions

What is Zimmer Biomet's stock symbol?

Zimmer Biomet trades on the New York Stock Exchange (NYSE) under the ticker symbol "ZBH."

How often does Zimmer Biomet pay dividends? What is the dividend yield for Zimmer Biomet?

Zimmer Biomet declared a quarterly dividend on Monday, December 18th. Stockholders of record on Friday, December 29th will be paid a dividend of $0.24 per share on Monday, January 29th. This represents a $0.96 dividend on an annualized basis and a dividend yield of 0.81%. The ex-dividend date is Thursday, December 28th. View Zimmer Biomet's Dividend History.

How were Zimmer Biomet's earnings last quarter?

Zimmer Biomet Holdings Inc (NYSE:ZBH) posted its quarterly earnings results on Tuesday, January, 30th. The medical equipment provider reported $2.10 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.10 by $0.00. The medical equipment provider earned $2.07 billion during the quarter, compared to the consensus estimate of $2.03 billion. Zimmer Biomet had a return on equity of 15.45% and a net margin of 23.51%. Zimmer Biomet's revenue for the quarter was up 3.0% compared to the same quarter last year. During the same period in the previous year, the business earned $2.14 EPS. View Zimmer Biomet's Earnings History.

When will Zimmer Biomet make its next earnings announcement?

Zimmer Biomet is scheduled to release their next quarterly earnings announcement on Wednesday, April, 25th 2018. View Earnings Estimates for Zimmer Biomet.

What guidance has Zimmer Biomet issued on next quarter's earnings?

Zimmer Biomet updated its first quarter earnings guidance on Tuesday, January, 30th. The company provided EPS guidance of $1.84-$1.91 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.02. The company issued revenue guidance of $1.955-$1.995 billion, compared to the consensus revenue estimate of $2.01 billion.

Where is Zimmer Biomet's stock going? Where will Zimmer Biomet's stock price be in 2018?

21 brokerages have issued 12 month price targets for Zimmer Biomet's shares. Their predictions range from $125.00 to $168.00. On average, they anticipate Zimmer Biomet's share price to reach $141.67 in the next twelve months. View Analyst Ratings for Zimmer Biomet.

What are Wall Street analysts saying about Zimmer Biomet stock?

Here are some recent quotes from research analysts about Zimmer Biomet stock:

  • 1. Cantor Fitzgerald analysts commented, "ZBH received FDA clearance for its Persona cementless knee, earlier than we expected." (2/5/2018)
  • 2. Canaccord Genuity analysts commented, "We maintain our HOLD rating following the announcement that Zimmer has named Bryan Hanson, former EVP and President of Medtronic’s Minimally Invasive Therapies Group, as CEO effective immediately. The announcement ends the five-month search for a new leader after former CEO David Dvorak resigned early in the Q3/17. Additionally, interim CEO Dan Florin will remain with the company as CFO. We view the hire positively as it removes the near-term overhang of management uncertainty and adds a seasoned medtech veteran to the management team and board. Additionally, we expect the new CEO to be well received by investors given our recent diligence suggested Mr. Hanson was at the top of investors’ short list of potential candidates." (12/19/2017)
  • 3. According to Zacks Investment Research, "Zimmer Biomet ended the third quarter 2017 on a dismal note with earnings below the Zacks Consensus Estimate and revenues in line with the same. Sales were declining within most of the core segments primarily due to the slower pace of supply recovery and sales recapture of certain key brands particularly in the United States and softened domestic market conditions. The lowered 2017 guidance also added to our concerns indicating little chances of recovery ahead. Over, the last three months, the company has been observed to trade below the broader industry. Nevertheless, we look forward to the expected synergy from the LDR Holding acquisition, which should broaden and complement the company's musculoskeletal offering. We are also impressed by the strong strategic and financial goals which the combined entity expects to reach, now that the deal has been closed." (11/20/2017)

Who are some of Zimmer Biomet's key competitors?

Who are Zimmer Biomet's key executives?

Zimmer Biomet's management team includes the folowing people:

  • Bryan C. Hanson, President, Chief Executive Officer, Director (Age 50)
  • Daniel P. Florin, Chief Financial Officer, Senior Vice President (Age 53)
  • Robert D. Delps, President, Americas
  • Katarzyna Mazur-Hofsaess M.D. Ph.D., President, Europe, Middle East and Africa (Age 52)
  • Sang Yi, President, Asia Pacific (Age 54)
  • Chad F. Phipps, Senior Vice President, General Counsel, Secretary (Age 44)
  • Larry C. Glasscock, Independent Non-Executive Chairman of the Board (Age 69)
  • Christopher B. Begley, Independent Director (Age 65)
  • Betsy J. Bernard, Independent Director (Age 61)
  • Gail Koziara Boudreaux, Independent Director (Age 56)

Who owns Zimmer Biomet stock?

Zimmer Biomet's stock is owned by many different of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (8.66%), Longview Partners Guernsey LTD (3.96%), American Century Companies Inc. (2.36%), OppenheimerFunds Inc. (1.31%), Bank of New York Mellon Corp (1.30%) and Geode Capital Management LLC (1.07%). Company insiders that own Zimmer Biomet stock include Bryan C Hanson, Chad F Phipps, Daniel E Williamson, Daniel P Florin, David A Jr Nolan, David C Dvorak, Sang Yi, Stuart G Kleopfer and Tony W Collins. View Institutional Ownership Trends for Zimmer Biomet.

Who sold Zimmer Biomet stock? Who is selling Zimmer Biomet stock?

Zimmer Biomet's stock was sold by a variety of institutional investors in the last quarter, including Thrivent Financial For Lutherans, BlackRock Inc., Boston Partners, Bridger Management LLC, AXA, Cramer Rosenthal Mcglynn LLC, Eaton Vance Management and Commerce Bank. Company insiders that have sold Zimmer Biomet company stock in the last year include Chad F Phipps, David C Dvorak, Sang Yi and Tony W Collins. View Insider Buying and Selling for Zimmer Biomet.

Who bought Zimmer Biomet stock? Who is buying Zimmer Biomet stock?

Zimmer Biomet's stock was acquired by a variety of institutional investors in the last quarter, including Wells Fargo & Company MN, Two Sigma Advisers LP, American Century Companies Inc., Longview Partners Guernsey LTD, TIAA CREF Investment Management LLC, Brandywine Global Investment Management LLC, OppenheimerFunds Inc. and Ascend Capital LLC. View Insider Buying and Selling for Zimmer Biomet.

How do I buy Zimmer Biomet stock?

Shares of Zimmer Biomet can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Zimmer Biomet's stock price today?

One share of Zimmer Biomet stock can currently be purchased for approximately $118.85.

How big of a company is Zimmer Biomet?

Zimmer Biomet has a market capitalization of $24.03 billion and generates $7.82 billion in revenue each year. The medical equipment provider earns $1.84 billion in net income (profit) each year or $9.01 on an earnings per share basis. Zimmer Biomet employs 18,500 workers across the globe.

How can I contact Zimmer Biomet?

Zimmer Biomet's mailing address is 345 EAST MAIN STREET, WARSAW IN, 46580. The medical equipment provider can be reached via phone at 574-267-6131 or via email at [email protected]


MarketBeat Community Rating for Zimmer Biomet (ZBH)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  582 (Vote Outperform)
Underperform Votes:  451 (Vote Underperform)
Total Votes:  1,033
MarketBeat's community ratings are surveys of what our community members think about Zimmer Biomet and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Zimmer Biomet (NYSE:ZBH) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.862.812.682.67
Ratings Breakdown: 0 Sell Rating(s)
4 Hold Rating(s)
16 Buy Rating(s)
1 Strong Buy Rating(s)
0 Sell Rating(s)
5 Hold Rating(s)
15 Buy Rating(s)
1 Strong Buy Rating(s)
1 Sell Rating(s)
6 Hold Rating(s)
14 Buy Rating(s)
1 Strong Buy Rating(s)
1 Sell Rating(s)
6 Hold Rating(s)
13 Buy Rating(s)
1 Strong Buy Rating(s)
Consensus Price Target: $141.67$137.42$135.40$138.68
Price Target Upside: 11.39% upside10.17% upside21.92% upside23.52% upside

Zimmer Biomet (NYSE:ZBH) Consensus Price Target History

Price Target History for Zimmer Biomet (NYSE:ZBH)

Zimmer Biomet (NYSE:ZBH) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/5/2018Cantor FitzgeraldReiterated RatingBuy$140.00HighView Rating Details
1/30/2018BMO Capital MarketsReiterated RatingBuy$144.00LowView Rating Details
1/31/2018Leerink SwannBoost Price TargetOutperform -> Outperform$142.00 -> $146.00LowView Rating Details
1/31/2018Stifel NicolausUpgradeHold -> Buy$120.00 -> $168.00LowView Rating Details
1/31/2018Robert W. BairdReiterated RatingBuyLowView Rating Details
1/30/2018Needham & Company LLCBoost Price TargetStrong-Buy -> Strong-Buy$144.00 -> $155.00MediumView Rating Details
1/29/2018SunTrust BanksBoost Price TargetBuy$142.00MediumView Rating Details
1/29/2018Morgan StanleyBoost Price Target$140.00 -> $150.00MediumView Rating Details
1/5/2018Canaccord GenuityReiterated RatingHold$132.00LowView Rating Details
12/19/2017Goldman Sachs GroupUpgradeSell -> Neutral$125.00LowView Rating Details
12/19/2017OppenheimerReiterated RatingBuyMediumView Rating Details
12/19/2017Wells Fargo & CoUpgradeMarket Perform -> OutperformLowView Rating Details
11/14/2017Deutsche BankUpgradeHold -> Buy$128.00N/AView Rating Details
11/9/2017Edward JonesUpgradeHold -> BuyN/AView Rating Details
11/7/2017Royal Bank of CanadaLower Price TargetOutperform$125.00N/AView Rating Details
11/3/2017Jefferies GroupReiterated RatingBuy$136.00N/AView Rating Details
11/2/2017Piper Jaffray CompaniesDowngradeOverweight -> NeutralN/AView Rating Details
8/24/2017GabelliInitiated CoverageBuy$142.00LowView Rating Details
7/14/2017Bank of AmericaReiterated RatingBuy -> Buy$158.00MediumView Rating Details
7/12/2017GuggenheimUpgradeNeutral -> Buy$157.00MediumView Rating Details
6/9/2017CitigroupBoost Price TargetNeutral$108.00 -> $130.00LowView Rating Details
1/5/2017JPMorgan Chase & Co.Set Price TargetBuy$134.00N/AView Rating Details
11/8/2016Northcoast ResearchDowngradeBuy -> NeutralN/AView Rating Details
9/22/2016ArgusReiterated RatingBuy$140.00N/AView Rating Details
8/23/2016BarclaysBoost Price TargetOverweight$140.00 -> $145.00N/AView Rating Details
7/29/2016JMP SecuritiesBoost Price TargetMarket Outperform$131.00 -> $145.00N/AView Rating Details
5/16/2016Sterne Agee CRTReiterated RatingBuyN/AView Rating Details
3/17/2016NomuraInitiated CoverageBuy$123.00N/AView Rating Details
(Data available from 2/23/2016 forward)

Earnings

Zimmer Biomet (NYSE:ZBH) Earnings History and Estimates Chart

Earnings by Quarter for Zimmer Biomet (NYSE:ZBH)

Zimmer Biomet (NYSE ZBH) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/25/2018$1.97N/AView Earnings Details
1/30/2018Q4 2017$2.10$2.10$2.03 billion$2.07 billionViewListenView Earnings Details
11/1/2017Q3 2017$1.74$1.72$1.83 billion$1.82 billionViewN/AView Earnings Details
7/27/2017Q2 2017$2.10$2.08$1.95 billion$1.95 billionViewN/AView Earnings Details
4/27/2017Q1 2017$2.11$2.13$1.96 billion$1.98 billionViewN/AView Earnings Details
1/31/2017Q416$2.11$2.14$1.98 billion$2.01 billionViewListenView Earnings Details
10/31/2016Q316$1.79$1.79$950.20 million$1.83 billionViewListenView Earnings Details
7/28/2016Q216$1.97$2.02$1.90 billion$1.93 billionViewListenView Earnings Details
4/28/2016Q116$1.93$2.00$1.88 billion$1.90 billionViewListenView Earnings Details
1/28/2016Q415$2.04$2.09$1.96 billion$1.98 billionViewListenView Earnings Details
10/29/2015Q315$1.56$1.64$1.76 billion$1.76 billionViewListenView Earnings Details
7/30/2015Q2 2015$1.56$1.59$1.14 billion$1.17 billionViewN/AView Earnings Details
4/30/2015Q115$1.54$1.58$1.15 billion$1.13 billionViewN/AView Earnings Details
1/29/2015Q414$1.71$0.91$1.25 billion$1.22 billionViewN/AView Earnings Details
10/23/2014Q314$1.00$0.96$1.10 billion$1.11 billionViewListenView Earnings Details
7/24/2014Q214$1.49$1.49$1.21 billion$1.18 billionViewN/AView Earnings Details
4/24/2014Q114$1.47$1.50$1.18 billion$1.16 billionViewListenView Earnings Details
1/31/2014Q114$1.62$1.36$1.22 billion$1.24 billionViewN/AView Earnings Details
10/24/2013Q313$1.24$1.25$1.06 billion$1.07 billionViewN/AView Earnings Details
7/25/2013Q2 2013$1.44$1.43$1.15 billion$1.17 billionViewN/AView Earnings Details
4/25/2013Q1 2013$1.40$1.41$1.14 billion$1.14 billionViewN/AView Earnings Details
1/31/2013Q4 2012$1.49$1.51$1.17 billion$1.18 billionViewN/AView Earnings Details
10/25/2012$1.13$1.15ViewN/AView Earnings Details
7/26/2012$1.32$1.34ViewN/AView Earnings Details
4/26/2012$1.30$1.30ViewN/AView Earnings Details
1/26/2012$1.34$1.36ViewN/AView Earnings Details
10/27/2011$1.03$1.04ViewN/AView Earnings Details
7/27/2011$1.19$1.21ViewN/AView Earnings Details
4/28/2011$1.12$1.19ViewN/AView Earnings Details
1/27/2011$1.19$1.21ViewN/AView Earnings Details
10/28/2010Q3 2010$0.95$0.96ViewN/AView Earnings Details
7/22/2010Q2 2010$1.05$1.09ViewN/AView Earnings Details
4/22/2010Q1 2010$1.01$1.02ViewN/AView Earnings Details
1/28/2010Q4 2009$1.08$1.12ViewN/AView Earnings Details
10/22/2009Q3 2009$0.85$0.88ViewN/AView Earnings Details
7/23/2009Q2 2009$0.96$1.01ViewN/AView Earnings Details
4/23/2009Q1 2009$0.94$0.95ViewN/AView Earnings Details
1/29/2009Q4 2008$1.00$1.00ViewN/AView Earnings Details
10/23/2008Q3 2008$0.89$0.97ViewN/AView Earnings Details
7/22/2008Q2 2008$1.03$1.03ViewN/AView Earnings Details
4/24/2008Q1 2008$1.04$1.04ViewN/AView Earnings Details
1/29/2008Q4 2007$1.04$1.18ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Zimmer Biomet (NYSE:ZBH) Earnings Estimates

2018 EPS Consensus Estimate: $7.78
2019 EPS Consensus Estimate: $8.21
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20186$1.85$1.98$1.89
Q2 20186$1.85$1.97$1.91
Q3 20186$1.73$1.84$1.79
Q4 20186$2.13$2.28$2.19
Q1 20192$1.98$2.04$2.01
Q2 20192$2.00$2.07$2.04
Q3 20192$1.87$1.91$1.89
Q4 20192$2.26$2.28$2.27
(Earnings estimates data provided by Zacks Investment Research)

Dividends

Zimmer Biomet (NYSE:ZBH) Dividend Information

Most Recent Dividend:1/29/2018
Annual Dividend:$0.96
Dividend Yield:0.81%
Dividend Growth:0.00% (3 Year Average)
Payout Ratio:10.65% (Trailing 12 Months of Earnings)
12.28% (Based on This Year's Estimates)
11.47% (Based on Next Year's Estimates)
Track Record:2 Years of Consecutive Dividend Growth
Frequency:Quarterly Dividend
Dividend Payments by Quarter for Zimmer Biomet (NYSE:ZBH)

Zimmer Biomet (NYSE:ZBH) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
12/18/2017quarterly$0.240.79%12/28/201712/29/20171/29/2018
8/7/2017quarterly$0.240.83%9/21/20179/22/201710/27/2017
5/30/2017quarterly$0.240.81%6/21/20176/23/20177/28/2017
3/1/2017quarterly$0.240.81%3/29/20173/31/20174/28/2017
12/19/2016quarterly$0.240.94%12/28/201612/30/20161/27/2017
8/23/2016quarterly$0.240.74%9/21/20169/23/201610/28/2016
5/23/2016quarterly$0.246/22/20166/24/20167/29/2016
2/24/2016quarterly$0.240.99%3/29/20163/31/20164/29/2016
12/14/2015quarterly$0.220.87%12/29/201512/31/20151/29/2016
8/24/2015quarterly$0.220.9%9/28/20159/30/201510/30/2015
5/5/2015quarterly$0.220.8%5/13/20155/15/20157/14/2015
2/24/2015quarterly$0.220.73%3/4/20153/6/20154/24/2015
12/15/2014quarterly$0.220.81%12/24/201412/29/20141/30/2015
8/26/2014quarterly$0.220.87%9/24/20149/26/201410/31/2014
5/23/2014quarterly$0.220.86%6/25/20146/27/20147/25/2014
3/5/2014quarterly$0.220.9%3/26/20143/28/20144/25/2014
12/16/2013quarterly$0.200.88%12/24/201312/27/20131/31/2014
9/9/2013quarterly$0.200.99%9/25/20139/27/201310/25/2013
6/14/2013quarterly$0.201.03%6/26/20136/28/20137/26/2013
3/8/2013quarterly$0.201.06%3/26/20133/29/20134/26/2013
12/14/2012quarterly$0.181.06%12/24/201212/27/20121/25/2013
(Data available from 1/1/2013 forward)

Insider Trades

Zimmer Biomet (NYSE ZBH) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 1.07%
Institutional Ownership Percentage: 88.18%
Insider Trades by Quarter for Zimmer Biomet (NYSE:ZBH)
Institutional Ownership by Quarter for Zimmer Biomet (NYSE:ZBH)

Zimmer Biomet (NYSE ZBH) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/20/2018Bryan C HansonInsiderBuy25,077$119.68$3,001,215.36View SEC Filing  
2/12/2018Chad F. PhippsVPSell20,826$115.95$2,414,774.70View SEC Filing  
7/31/2017Tony W. CollinsVPSell16,986$121.74$2,067,875.64View SEC Filing  
6/12/2017Sang YiInsiderSell17,731$124.56$2,208,573.36View SEC Filing  
5/5/2017Chad F. PhippsVPSell6,200$116.76$723,912.00View SEC Filing  
4/27/2017David C DvorakInsiderSell87,331$116.47$10,171,441.57381,886View SEC Filing  
3/20/2017David C DvorakInsiderSell1,040$121.63$126,495.20294,077View SEC Filing  
12/2/2016David A. Jr. NolanInsiderSell5,050$101.11$510,605.50View SEC Filing  
9/8/2016Daniel E WilliamsonInsiderSell2,716$129.96$352,971.362,000View SEC Filing  
8/23/2016Stuart G KleopferInsiderSell3,397$129.71$440,624.873,000View SEC Filing  
8/12/2016Tony W. CollinsVPSell1,287$129.16$166,228.92View SEC Filing  
8/9/2016Stuart G KleopferInsiderSell533$132.71$70,734.436,397View SEC Filing  
8/1/2016David A. Jr. NolanInsiderSell25,255$130.77$3,302,596.35View SEC Filing  
7/11/2016Daniel P FlorinCFOSell15,000$124.98$1,874,700.0016,983View SEC Filing  
6/14/2016Tony W CollinsCAOSell3,611$116.43$420,428.733,245View SEC Filing  
6/9/2016Stuart G KleopferInsiderSell11,000$119.45$1,313,950.007,609View SEC Filing  
4/14/2016Daniel P FlorinCFOSell10,000$114.98$1,149,800.0028,415View SEC Filing  
4/12/2016Daniel P FlorinCFOSell12,000$110.00$1,320,000.0038,415View SEC Filing  
3/21/2016David C DvorakCEOSell1,540$104.16$160,406.40277,416View SEC Filing  
2/10/2016Blackstone Capital Partners VMajor ShareholderSell7,351,708$95.91$705,102,314.28View SEC Filing  
1/8/2016David C. DvorakCEOSell44,661$102.46$4,575,966.06244,502View SEC Filing  
12/2/2015David A. Jr. NolaninsiderSell3,435$102.62$352,499.7012,139View SEC Filing  
6/30/2015Adam Rudolph JohnsonInsiderSell30,600$110.34$3,376,404.00View SEC Filing  
6/29/2015Daniel E WilliamsonInsiderSell16,000$110.98$1,775,680.00View SEC Filing  
6/29/2015Daniel P FlorinCFOSell5,000$107.00$535,000.00View SEC Filing  
3/17/2015David C DvorakCEOSell1,300$115.55$150,215.00View SEC Filing  
12/5/2014David C DvorakCEOSell48,703$115.00$5,600,845.00View SEC Filing  
11/28/2014Chad F PhippsVPSell5,000$112.00$560,000.00View SEC Filing  
11/3/2014Katarzyna Mazur-HofsaessInsiderSell28,253$110.01$3,108,112.53View SEC Filing  
9/9/2014Stephen Hong Liang OoiInsiderSell40,768$102.78$4,190,135.04View SEC Filing  
8/26/2014James T CrinesCFOSell40,768$101.00$4,117,568.00View SEC Filing  
1/8/2014Jeffery MccaulleyInsiderSell21,286$96.00$2,043,456.005,211View SEC Filing  
1/7/2014Chad PhippsVPSell7,000$95.00$665,000.0017,240View SEC Filing  
12/20/2013Jeffery MccaulleyInsiderSell21,286$93.00$1,979,598.005,211View SEC Filing  
12/3/2013Jeffery MccaulleyInsiderSell2,713$90.12$244,495.565,211View SEC Filing  
11/15/2013Derek DavisCAOSell3,500$90.20$315,700.002,791View SEC Filing  
11/14/2013Chad PhippsVPSell7,800$90.00$702,000.0017,240View SEC Filing  
11/14/2013David DvorakCEOSell64,763$90.00$5,828,670.00172,746View SEC Filing  
11/14/2013Jeffery MccaulleyInsiderSell21,285$90.00$1,915,650.007,924View SEC Filing  
9/13/2013Katarzyna Mazur-HofsaessInsiderSell4,890$81.38$397,948.201,643View SEC Filing  
8/1/2013James T CrinesCFOSell46,200$84.56$3,906,672.00View SEC Filing  
8/1/2013Stephen Hong Liang OoiInsiderSell38,500$84.27$3,244,395.00View SEC Filing  
7/29/2013Derek M DavisCAOSell3,725$83.78$312,080.50View SEC Filing  
7/29/2013Jeffery A MccaulleyInsiderSell112,255$83.40$9,362,067.00View SEC Filing  
7/19/2013Chad F PhippsVPSell6,000$83.00$498,000.00View SEC Filing  
5/8/2013Chad F PhippsVPSell5,000$77.26$386,300.00View SEC Filing  
4/30/2013James T CrinesCFOSell25,000$76.08$1,902,000.00View SEC Filing  
4/30/2013Jeffery A MccaulleyInsiderSell10,000$76.08$760,800.00View SEC Filing  
2/4/2013Derek M DavisCAOSell21,864$72.53$1,585,795.92View SEC Filing  
2/4/2013Jeffery A MccaulleyInsiderSell12,000$73.60$883,200.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Zimmer Biomet (NYSE ZBH) News Headlines

Source:
DateHeadline
Zimmer Biomet Holdings Inc (ZBH) President and CEO Bryan C Hanson Bought $3 million of SharesZimmer Biomet Holdings Inc (ZBH) President and CEO Bryan C Hanson Bought $3 million of Shares
finance.yahoo.com - February 21 at 8:46 AM
Bryan C. Hanson Purchases 25,077 Shares of Zimmer Biomet Holdings Inc (ZBH) StockBryan C. Hanson Purchases 25,077 Shares of Zimmer Biomet Holdings Inc (ZBH) Stock
www.americanbankingnews.com - February 20 at 6:20 PM
 Analysts Anticipate Zimmer Biomet Holdings Inc (ZBH) Will Post Quarterly Sales of $1.98 Billion Analysts Anticipate Zimmer Biomet Holdings Inc (ZBH) Will Post Quarterly Sales of $1.98 Billion
www.americanbankingnews.com - February 19 at 2:40 AM
Zacks: Analysts Expect Zimmer Biomet Holdings Inc (ZBH) Will Post Earnings of $1.87 Per ShareZacks: Analysts Expect Zimmer Biomet Holdings Inc (ZBH) Will Post Earnings of $1.87 Per Share
www.americanbankingnews.com - February 17 at 11:16 PM
Insider Selling: Zimmer Biomet Holdings Inc (ZBH) VP Sells 20,826 Shares of StockInsider Selling: Zimmer Biomet Holdings Inc (ZBH) VP Sells 20,826 Shares of Stock
www.americanbankingnews.com - February 14 at 12:16 PM
Zimmer Biomets Rapid Recovery Program Marks Two Decades of Success in EuropeZimmer Biomet's Rapid Recovery Program Marks Two Decades of Success in Europe
finance.yahoo.com - February 9 at 9:40 AM
Cantor Fitzgerald Reaffirms "Buy" Rating for Zimmer Biomet (ZBH)Cantor Fitzgerald Reaffirms "Buy" Rating for Zimmer Biomet (ZBH)
www.americanbankingnews.com - February 5 at 12:26 PM
Brokers Issue Forecasts for Zimmer Biomet Holdings Incs FY2019 Earnings (ZBH)Brokers Issue Forecasts for Zimmer Biomet Holdings Inc's FY2019 Earnings (ZBH)
www.americanbankingnews.com - February 2 at 3:42 PM
FY2018 Earnings Forecast for Zimmer Biomet Holdings Inc Issued By Cantor Fitzgerald (ZBH)FY2018 Earnings Forecast for Zimmer Biomet Holdings Inc Issued By Cantor Fitzgerald (ZBH)
www.americanbankingnews.com - February 2 at 12:21 PM
Q1 2018 EPS Estimates for Zimmer Biomet Holdings Inc Cut by Analyst (ZBH)Q1 2018 EPS Estimates for Zimmer Biomet Holdings Inc Cut by Analyst (ZBH)
www.americanbankingnews.com - February 2 at 8:34 AM
Zimmer Biomet Holdings Inc (ZBH) Expected to Announce Quarterly Sales of $2.00 BillionZimmer Biomet Holdings Inc (ZBH) Expected to Announce Quarterly Sales of $2.00 Billion
www.americanbankingnews.com - February 2 at 2:22 AM
Zimmer Biomet Holdings, Inc. -- Moodys revises Zimmer Biomets outlook to stable from negative, Baa3 rating affirmedZimmer Biomet Holdings, Inc. -- Moody's revises Zimmer Biomet's outlook to stable from negative, Baa3 rating affirmed
finance.yahoo.com - February 1 at 3:57 PM
Analysts Issue Forecasts for Zimmer Biomet Holdings Incs FY2018 Earnings (ZBH)Analysts Issue Forecasts for Zimmer Biomet Holdings Inc's FY2018 Earnings (ZBH)
www.americanbankingnews.com - February 1 at 11:49 AM
Jefferies Group Weighs in on Zimmer Biomet Holdings Incs Q2 2018 Earnings (ZBH)Jefferies Group Weighs in on Zimmer Biomet Holdings Inc's Q2 2018 Earnings (ZBH)
www.americanbankingnews.com - February 1 at 9:36 AM
Q1 2018 EPS Estimates for Zimmer Biomet Holdings Inc (ZBH) Lowered by William BlairQ1 2018 EPS Estimates for Zimmer Biomet Holdings Inc (ZBH) Lowered by William Blair
www.americanbankingnews.com - February 1 at 9:08 AM
Zimmer Biomet Holdings Inc Expected to Post Q1 2018 Earnings of $1.87 Per Share (ZBH)Zimmer Biomet Holdings Inc Expected to Post Q1 2018 Earnings of $1.87 Per Share (ZBH)
www.americanbankingnews.com - February 1 at 9:02 AM
Q1 2018 EPS Estimates for Zimmer Biomet Holdings Inc (ZBH) Reduced by AnalystQ1 2018 EPS Estimates for Zimmer Biomet Holdings Inc (ZBH) Reduced by Analyst
www.americanbankingnews.com - February 1 at 9:02 AM
Leerink Swann Equities Analysts Decrease Earnings Estimates for Zimmer Biomet Holdings Inc (ZBH)Leerink Swann Equities Analysts Decrease Earnings Estimates for Zimmer Biomet Holdings Inc (ZBH)
www.americanbankingnews.com - February 1 at 7:48 AM
Zimmer Biomets (ZBH) "Buy" Rating Reiterated at Cantor FitzgeraldZimmer Biomet's (ZBH) "Buy" Rating Reiterated at Cantor Fitzgerald
www.americanbankingnews.com - January 31 at 3:54 PM
Zimmer Biomets (ZBH) "Buy" Rating Reiterated at BMO Capital MarketsZimmer Biomet's (ZBH) "Buy" Rating Reiterated at BMO Capital Markets
www.americanbankingnews.com - January 31 at 3:54 PM
Leerink Swann Increases Zimmer Biomet (ZBH) Price Target to $146.00Leerink Swann Increases Zimmer Biomet (ZBH) Price Target to $146.00
www.americanbankingnews.com - January 31 at 11:38 AM
Zimmer Biomet (ZBH) Q4 Earnings Meet Estimates, Sales Beat (Revised)Zimmer Biomet (ZBH) Q4 Earnings Meet Estimates, Sales Beat (Revised)
finance.yahoo.com - January 30 at 4:00 PM
Zimmer Biomet (ZBH) PT Raised to $155.00Zimmer Biomet (ZBH) PT Raised to $155.00
www.americanbankingnews.com - January 30 at 2:14 PM
Zimmer Biomet Holdings Inc. Reveals Decline In Q4 EarningsZimmer Biomet Holdings Inc. Reveals Decline In Q4 Earnings
www.nasdaq.com - January 30 at 10:15 AM
Zimmer Biomet Holdings, Inc. to Host Earnings CallZimmer Biomet Holdings, Inc. to Host Earnings Call
finance.yahoo.com - January 30 at 10:15 AM
Zimmer Biomet Announces Fourth Quarter and Full-Year 2017 ResultsZimmer Biomet Announces Fourth Quarter and Full-Year 2017 Results
finance.yahoo.com - January 30 at 10:15 AM
Zimmer meets 4Q profit forecastsZimmer meets 4Q profit forecasts
finance.yahoo.com - January 30 at 10:15 AM
Zimmer Biomet (ZBH) Q4 Earnings Meet, Sales Miss EstimatesZimmer Biomet (ZBH) Q4 Earnings Meet, Sales Miss Estimates
finance.yahoo.com - January 30 at 10:15 AM
Zimmer Biomet (ZBH) Releases  Earnings Results, Meets ExpectationsZimmer Biomet (ZBH) Releases Earnings Results, Meets Expectations
www.americanbankingnews.com - January 30 at 8:57 AM
Zimmer Biomet (ZBH) Updates Q1 Earnings GuidanceZimmer Biomet (ZBH) Updates Q1 Earnings Guidance
www.americanbankingnews.com - January 30 at 8:56 AM
Zimmer Biomet Holdings Inc (ZBH) Given Average Recommendation of "Buy" by BrokeragesZimmer Biomet Holdings Inc (ZBH) Given Average Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - January 30 at 5:24 AM
Morgan Stanley Raises Zimmer Biomet (ZBH) Price Target to $150.00Morgan Stanley Raises Zimmer Biomet (ZBH) Price Target to $150.00
www.americanbankingnews.com - January 29 at 9:36 PM
SunTrust Banks Raises Zimmer Biomet (ZBH) Price Target to $142.00SunTrust Banks Raises Zimmer Biomet (ZBH) Price Target to $142.00
www.americanbankingnews.com - January 29 at 8:34 PM
Zimmer Biomet Target of Unusually High Options Trading (ZBH)Zimmer Biomet Target of Unusually High Options Trading (ZBH)
www.americanbankingnews.com - January 27 at 1:44 AM
Q1 2018 EPS Estimates for Zimmer Biomet Holdings Inc Reduced by Analyst (ZBH)Q1 2018 EPS Estimates for Zimmer Biomet Holdings Inc Reduced by Analyst (ZBH)
www.americanbankingnews.com - January 23 at 8:54 AM
Will S.E.T. Arm Drive Zimmer Biomets (ZBH) Q4 Earnings?Will S.E.T. Arm Drive Zimmer Biomet's (ZBH) Q4 Earnings?
www.zacks.com - January 22 at 11:19 AM
Will S.E.T. Arm Drive Zimmer Biomet's (ZBH) Q4 Earnings?Will S.E.T. Arm Drive Zimmer Biomet's (ZBH) Q4 Earnings?
finance.yahoo.com - January 22 at 11:19 AM
Zimmer Biomet (ZBH) to Release Earnings on MondayZimmer Biomet (ZBH) to Release Earnings on Monday
www.americanbankingnews.com - January 22 at 5:46 AM
$2.10 Earnings Per Share Expected for Zimmer Biomet Holdings Inc (ZBH) This Quarter$2.10 Earnings Per Share Expected for Zimmer Biomet Holdings Inc (ZBH) This Quarter
www.americanbankingnews.com - January 15 at 1:08 AM
Equities Analysts Offer Predictions for Zimmer Biomet Holdings Incs FY2017 Earnings (ZBH)Equities Analysts Offer Predictions for Zimmer Biomet Holdings Inc's FY2017 Earnings (ZBH)
www.americanbankingnews.com - January 10 at 6:28 AM
FDA Nod for Zimmer Biomets Sidus, Aids Arthroplasty ArmFDA Nod for Zimmer Biomet's Sidus, Aids Arthroplasty Arm
www.zacks.com - January 8 at 10:41 AM
FDA Nod for Zimmer Biomet's Sidus, Aids Arthroplasty ArmFDA Nod for Zimmer Biomet's Sidus, Aids Arthroplasty Arm
finance.yahoo.com - January 8 at 10:41 AM
Zimmer Biomet (ZBH) Rating Reiterated by Cantor FitzgeraldZimmer Biomet (ZBH) Rating Reiterated by Cantor Fitzgerald
www.americanbankingnews.com - January 6 at 11:10 PM
Zimmer Biomet (ZBH) Given Hold Rating at Canaccord GenuityZimmer Biomet (ZBH) Given Hold Rating at Canaccord Genuity
www.americanbankingnews.com - January 5 at 1:34 PM
Zimmer Biomet Holdings (ZBH) FDA Clearance of the Sidus Stem-Free Shoulder System - StreetInsider.comZimmer Biomet Holdings (ZBH) FDA Clearance of the Sidus Stem-Free Shoulder System - StreetInsider.com
www.streetinsider.com - January 5 at 10:42 AM
Zimmer Biomet Holdings (ZBH) FDA Clearance of the Sidus Stem-Free Shoulder SystemZimmer Biomet Holdings (ZBH) FDA Clearance of the Sidus Stem-Free Shoulder System
www.streetinsider.com - January 4 at 10:26 AM
Zimmer Biomet Announces FDA Clearance of the Sidus® Stem-Free Shoulder SystemZimmer Biomet Announces FDA Clearance of the Sidus® Stem-Free Shoulder System
finance.yahoo.com - January 4 at 10:26 AM
What Zimmer Biomet’s Progress II Study Success Could MeanWhat Zimmer Biomet’s Progress II Study Success Could Mean
finance.yahoo.com - January 4 at 10:26 AM
Where Zimmer Biomet’s Leadership Stands NowWhere Zimmer Biomet’s Leadership Stands Now
finance.yahoo.com - January 3 at 4:22 PM
Zimmer Biomet on the Street: How the Analysts Are LeaningZimmer Biomet on the Street: How the Analysts Are Leaning
finance.yahoo.com - January 3 at 9:43 AM

SEC Filings

Zimmer Biomet (NYSE:ZBH) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Zimmer Biomet (NYSE:ZBH) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Zimmer Biomet (NYSE ZBH) Stock Chart for Friday, February, 23, 2018

Loading chart…

This page was last updated on 2/23/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.